| Literature DB >> 16722301 |
S Marntell1, G Nyman, P Funkquist.
Abstract
The principal aim of this study was to evaluate dissociative anaesthesia for castration of colts during field conditions. Three dissociative anaesthetic protocols were evaluated during castration of colts in an animal hospital. The protocol considered to be the most suitable was thereafter evaluated during castration of colts under field conditions. Respiratory and haemodynamic parameters and the response to surgery were determined during anaesthesia. All horses breathed air spontaneously during anaesthesia. Under hospital conditions 26 colts were randomised to receive one of three anaesthetic protocols: Romifidine and tiletamine-zolazepam (RZ); acepromazine, romifidine and tiletamine-zolazepam (ARZ); or acepromazine, romifidine, butorphanol and tiletamine-zolazepam (ARBZ). The surgeon was blinded to the anaesthetic protocol used and decided whether supplemental anaesthesia was needed to complete surgery. Under field conditions 31 colts were castrated during anaesthesia with the ARBZ protocol. All inductions, anaesthesia and recoveries were calm and without excitation under both hospital and field conditions. Surgery was performed within 5-20 minutes after the horses had assumed lateral recumbency during both hospital and field castrations. Under hospital conditions some horses needed supplemental anaesthesia with all three anaesthetic protocols to complete surgery. Interestingly, none of the horses castrated with protocol ARBZ under field conditions needed additional anaesthesia. Cardiorespiratory changes were within acceptable limits in these clinically healthy colts.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16722301 PMCID: PMC1618963 DOI: 10.1186/1751-0147-47-1
Source DB: PubMed Journal: Acta Vet Scand ISSN: 0044-605X Impact factor: 1.695
Reaction to surgery and the percent of horses that needed supplemental anaesthesia for completion of surgery
| Protocol | Surgery score median (range) | Supplemental anaesthesia percent of horses receiving |
| Hospital – RZ | 1.5 (1–2.5) | 50% |
| Hospital – ARZ | 3.5 (1–5) # | 27% # |
| Hospital – ARBZ | 3.5 (2–4.5) # | 22% # |
| Field – ARBZ | 5 (3–5) # * | 0% # * |
Reaction to surgery was scored from 1 to 5, were 5 is no reaction to surgery. Romifidine and tiletamine/zolazepam (RZ); acepromazine, romifidine and tiletamine/zolazepam (ARZ); acepromazine, romifidine, butorphanol and tiletamine/zolazepam (ARBZ). Hospital = surgery performed under hospital conditions, Field = surgery performed under field conditions # = Significantly different from RZ, * = Field-ARBZ significantly different from Hospital-ARBZ.
Cardiorespiratory data from castrations performed in animal hospital
| Variables | Protocol | ANE 5' | ANE 15' | ANE 25' | ANE 35' | Post | Within protocol | Between protocols |
| HR | RZ | 34 (4) | 36 (3) | 34 (2) | 32 (0) | 34 (6) | NS | NS |
| Beats/min | ARZ | 35 (4) | 35 (4) | 35 (4) | 36 (7) | 37 (3) | NS | |
| ARBZ | 33 (5) | 32 (4) | 33 (6) | 34 (7) | 33 (7) | NS | ||
| SAP mean | RZ | 157 (27)* | 142 (26) | 131 (30) | 118 (16) | 107 (10) | 0.03 | RZ-ARZ 0.023 |
| mm Hg | ARZ | 136 (11) # | 123 (16)* # | 106 (17) # | 100 (11) # | 104 (6) | <0.01 | |
| ARBZ | 128 (20) # | 126 (16) # | 124 (22) # | 110 (19) # | 115 (22) | NS | ||
| RR | RZ | 24 (15) | 32 (13) | 24 (10) | 22 (4) | 17 (8) | NS | NS |
| Breaths/min | ARZ | 24 (10) | 33 (12) | 26 (8) | 27 (9) | [12 (4)] | NS | |
| ARBZ | 17 (6) | 19 (7) | 20 (7) | 19 (5) | 14 (3) | NS | ||
| PaCO2 | RZ | 5.9 (0.3) | 5.6 (0.5)* | 5.6 (0.4)* | [5.7 (0.2)] | 6.1 (0.3) | <0.01 | NS |
| kPa | ARZ | 6.2 (0.4) | 6.1 (0.6) | 6.0 (0.5) | 6.2 (0.4) | 6.0 (0.4) | NS | |
| ARBZ | 6.4 (0.5) | 6.1 (0.5) | 6.4 (0.3) | 6.3 (0.3) | 6.2 (0.4) | NS | ||
| PaO2 | RZ | 7.7 (1.0)* | 7.4 (1.0)* | 7.4 (1.5)* | [6.9 (0.3)] | 12.5 (0.8) | <0.01 | NS |
| kPa | ARZ | 8.0 (1.0)* | 8.0 (1.2)* | 8.1 (1.4)* | 8.6 (1.5)* | 12.9 (1.3) | <0.01 | |
| ARBZ | 8.3 (1.6)* | 8.4 (1.9)* | 7.5 (1.8)* | 8.4 (2.0)* | 13.5 (1.4) | <0.01 | ||
| PjvO2 | RZ | 4.2 (0.4) | 4.2 (0.3) | 4.2 (0.4) | [4.6 (0.4)] | 4.4 (0.6) | NS | RZ-ARBZ 0.003 |
| kPa | ARZ | 4.4 (0.4) | 4.5 (0.4) | 4.7 (0.5) | 4.7 (0.5) | 4.7 (0.6) | NS | |
| ARBZ | 5.0 (0.5) # | 4.9 (0.4) # | 4.8 (0.6) # | 5.0 (0.4) | 5.3 (0.5) # | NS | ||
| C(a-jv)O2 | RZ | 5.0 (1.0) | 4.5 (1.5) | 4.1 (2.2) | [2.8 (0.5)] | 5.0 (1.6) | NS | NS |
| ml/100 ml | ARZ | 4.4 (1.1) | 3.8 (1.0) | 3.4 (1.0) | 3.3 (1.0) | 4.0 (1.2) | NS | |
| ARBZ | 3.8 (0.8) | 3.7 (0.7) | 3.2 (0.5) | 2.9 (0.8) | 3.8 (1.1) | NS |
Data presented as mean (SD) for heart rate (HR), mean systemic arterial pressure (SAP mean), respiratory rate (RR), arterial carbon dioxide tension (PaCO2), arterial oxygen tension (PaO2), jugular venous oxygen tension (PjvO2) and arterial – jugular venous oxygen tension difference (C(a-jv)O2). Protocol = anaesthetic protocol: romifidine and tiletamine/zolazepam (RZ); acepromazine, romifidine and tiletamine/zolazepam (ARZ); acepromazine, romifidine, butorphanol and tiletamine/zolazepam (ARBZ). ANE 5', 15', 25' and 35' = measurements at 5, 15, 25 and 35 minutes of anaesthesia. Post = 5 minutes after the horse had regained the standing position. Within protocol = p value for 1-way ANOVA run for each protocol from ANE 5' to Post. * = Significant different compared to Post. Between protocol = p value for 2-way ANOVA during anaesthesia. # =significantly different from RZ. Values within brackets [] not included in statistical analysis (n = 3-5). NS = not significant.
Cardiorespiratory data from castrations performed in field conditions compared to hospital conditions with protocol ARBZ (acepromazine, romifidine, butorphanol and tiletamine/zolazepam)
| Variables | Protocol | n | Baseline | ANE 5' | ANE 15' | ANE 25' | ANE 35' | Post |
| HR | Hospital | n = 9 | 39 (3)* | 33 (5)B* | 32 (4)B* | 33 (6) B* | 34 (7)* | 33 (7)B* |
| Beats/min | Field | n = 31 | 44 (6) | 39 (6) | 41 (6) | 40 (5) | 40 (5) | 43 (10) |
| SAP mean | Hospital (invasive) | n = 9 | ND | 128 (20) | 126 (16) | 124 (22) | 110 (19) | 115 (22) |
| mm Hg | Field (non-invasive) | n = 6 | ND | 108 (16) | 114 (14) | 113 (21) | 114 (34) | ND |
| RR | Hospital | n = 9 | 18 (8) | 17 (6) | 19 (7) | 20 (7) | 19 (5) | 14 (3) |
| Breaths/min | Field | n = 31 | 15 (3) | 14 (6) | 19 (8) | 22 (7)B | 24 (7)B | 14 (6) |
| PaCO2 | Hospital | n = 9 | ND | 6.4 (0.5) | 6.1 (0.5) | 6.4 (0.3) | 6.3 (0.3) | 6.2 (0.4) |
| kPa | Field | n = 11 | ND | 6.7 (0.8) | 6.4 (0.6) | [6.1 (1.0)] (n = 4) | ND | ND |
| PaO2 | Hospital | n = 9 | ND | 8.3 (1.6) | 8.4 (1.9) | 7.5 (1.8) | 8.4 (2.0) | 13.5 (1.4) |
| kPa | Field | n = 11 | ND | 7.6 (0.8) | 8.1 (1.1) | [8.3 (0.7)] (n = 4) | ND | ND |
| PjvO2 | Hospital | n = 9 | ND | 5.0 (0.5) | 4.9 (0.4) | 4.8 (0.6) | 5.0 (0.4) | 5.3 (0.5) |
| kPa | Field | n = 9 | ND | 5.0 (0.5) | 5.1 (0.8) | [5.4 (0.6)] (n = 3) | ND | ND |
Data presented as mean (SD) for heart rate (HR), mean systemic arterial pressure (SAP mean), respiratory rate (RR), arterial carbon dioxide tension (PaCO2), arterial oxygen tension (PaO2), jugular venous oxygen tension (PjvO2). Baseline = measurements performed in the standing unsedated horse. ANE 5', 15', 25' and 35' = measurements at 5, 15, 25 and 35 minutes of anaesthesia. Post = 5 minutes after the horse had regained the standing position.* = Field conditions significantly different from hospital conditions. B = Significantly different from Baseline. ND = not determined. Values within brackets [] not included in statistical analysis.
Figure 1Difference between jugular venous oxygen tension (PjvO2) and mixed venous oxygen tension (PvO2) during anaesthesia with protocol ARBZ (acepromazine, romifidine, butorphanol and tiletamine-zolazepam). Difference between jugular and mixed venous oxygen tension in kPa is plotted on the y-axis and time spent in anaesthesia is plotted at the x-axis.